MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.5 CNY | +5.31% |
|
+6.32% | +5.54% |
| 24/05 | Mabwell Announces 9MW2821 Clinical Data | CI |
| 13/05 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. | Bio Therapeutic Drugs | +5.31% | +6.32% | +5.54% | +50.33% | - | 1.9B | - | - | - |
